Neurodegeneration Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Neurodegeneration stocks.

Neurodegeneration Stocks Recent News

Date Stock Title
Nov 1 ITCI Intra-Cellular Therapies Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
Oct 31 ABOS Acumen Pharmaceuticals Presents Innovative Trial Screening Advancements Utilizing pTau217 Assay in Phase 2 Study of Sabirnetug for Early Alzheimer’s Disease at the 17th Annual Clinical Trials on Alzheimer’s Disease Conference
Oct 31 ANVS IBN Announces Latest Episode of The BioMedWire Podcast Featuring Dr. Maria Maccecchini, CEO of Annovis Bio
Oct 31 ITCI Intra-Cellular Therapies Inc (ITCI) Q3 2024 Earnings Call Highlights: Robust Sales Growth and ...
Oct 30 ITCI Intra-Cellular Therapies, Inc. (ITCI) Q3 2024 Earnings Call Transcript
Oct 30 ITCI Intra-Cellular jumps on Q3 beat as Caplyta outlook brightens
Oct 30 ITCI ITCI Q3 Loss Wider Than Expected, Revenues Top on Higher Caplyta Sales
Oct 30 DNLI Analysts Estimate Arcus Biosciences, Inc. (RCUS) to Report a Decline in Earnings: What to Look Out for
Oct 30 ITCI Intra-Cellular Therapies (ITCI) Reports Q3 Loss, Tops Revenue Estimates
Oct 30 ITCI Intra-Cellular: Q3 Earnings Snapshot
Oct 30 ITCI Intra-Cellular Therapies GAAP EPS of -$0.25 misses by $0.04, revenue of $175.4M beats by $3.05M
Oct 30 ITCI Intra-Cellular Therapies Reports Third Quarter 2024 Financial Results, Provides Corporate Update and Raises 2024 Caplyta Sales Guidance
Oct 29 ITCI Intra-Cellular Therapies Q3 2024 Earnings Preview
Oct 29 PRTA Prothena (PRTA) Upgraded to Buy: What Does It Mean for the Stock?
Oct 29 DNLI Denali Therapeutics Inc. (DNLI) May Report Negative Earnings: Know the Trend Ahead of Q3 Release
Oct 29 PRTA Strength Seen in Prothena (PRTA): Can Its 15.0% Jump Turn into More Strength?
Oct 28 PRTA PROCEPT BioRobotics Posts Strong Q3 Earnings, Joins Monte Rosa Therapeutics, EyePoint Pharmaceuticals And Other Big Stocks Moving Higher On Monday
Oct 28 ACIU AC Immune SA (NASDAQ:ACIU) stock most popular amongst individual investors who own 32%, while private equity firms hold 29%
Oct 28 NRSN NeuroSense Secures Key FDA Meeting to Advance its Phase 3 ALS Trial and NDA Submission
Oct 28 NRSN EXCLUSIVE: Nano-Cap NeuroSense Schedules FDA Meeting To Advance Lead Program And Marketing Application Submission
Neurodegeneration

Neurodegeneration is the progressive loss of structure or function of neurons, including death of neurons. Many neurodegenerative diseases – including amyotrophic lateral sclerosis, Parkinson's disease, Alzheimer's disease, and Huntington's disease – occur as a result of neurodegenerative processes. Such diseases are incurable, resulting in progressive degeneration and/or death of neuron cells. As research progresses, many similarities appear that relate these diseases to one another on a sub-cellular level. Discovering these similarities offers hope for therapeutic advances that could ameliorate many diseases simultaneously. There are many parallels between different neurodegenerative disorders including atypical protein assemblies as well as induced cell death. Neurodegeneration can be found in many different levels of neuronal circuitry ranging from molecular to systemic.

Browse All Tags